KF012-HTC3
Basic Information
Sample Name: KF012-HTC3
Subject ID: 3385
Cell Type: PE enriched SARS-CoV-2 Spike+ B cells
Tissue Source: Blood
Condition: SLE
Treatment: Mycophenolate mofetil
Collection Date: 2024-07-09
Processing Date: 2024-05-28
Cell Ranger Quality Metrics
4,000
Cells Loaded
1,625
Cells Mapped
1,491
Cells Kept
40.6%
Mapping Rate
(Mapped / Loaded)91.8%
Retention Rate
(Kept / Mapped)Study-Specific Information
Sex: Female
Age: 50
Race: aa
Hashtag: HTC3
Number of Vaccinations: 3
Days Post-Vaccination: 47
Vaccine Type: moderna
Associated Assays
Quality Status:
Shows QC results for this sample in each assay.
Pending = awaiting review,
Passed = meets QC criteria,
Failed = below QC thresholds,
Flagged = needs attention.
Click the dropdown to update status.
| Assay Name | Type | Study | Position | Index Barcode | Quality Status |
|---|---|---|---|---|---|
| KF012-scRNA-seq | scRNA-seq | EXP2 | - | - | |
| KF012-CITE-seq | CITE-seq | EXP2 | - | - | |
| KF012-scVDJ-seq | scVDJ-seq | EXP2 | - | - |
Sample Timeline
Created:
2025-09-03 14:21 UTC
2025-09-03 14:21 UTC
Collected:
2024-07-09
2024-07-09
Processed:
2024-05-28
2024-05-28
Last Updated:
2025-11-20 16:43 UTC
2025-11-20 16:43 UTC